CELGENE CORP /DE/

10% owner at Abraxis BioScience, Inc. · on record since Jul 9, 2010
10% owner at Adynxx, Inc. · on record since Nov 19, 2013
10% owner at CRISPR Therapeutics AG · on record since Oct 27, 2016
10% owner at Epizyme, Inc. · on record since May 30, 2013
10% owner at AGIOS PHARMACEUTICALS, INC. · on record since Jul 30, 2013
10% owner at ACCELERON PHARMA INC · on record since Sep 26, 2013
10% owner at GLOBEIMMUNE INC · on record since Jul 8, 2014
10% owner at Receptos, Inc. · on record since Aug 27, 2015
10% owner at Jounce Therapeutics, Inc. · on record since Jan 26, 2017
10% owner at JUNO LIGHTING INC · on record since Mar 6, 2018
10% owner at SUTRO BIOPHARMA, INC. · on record since Sep 26, 2018
10% owner at CASI Pharmaceuticals, Inc (DE) · on record since Apr 1, 2005

Insider trading activity of CELGENE CORP /DE/

Transactions on record: 64; since Apr 1, 2005

Open-market buys: 16; $315.2M

Open-market sells: 21; $19.8M

Companies traded: 7; last filing Jul 13, 2020

Figures computed from official regulatory filings — .

Companies where CELGENE CORP /DE/ has traded

ACCELERON PHARMA INC16 tx · $172.6M · Jul 13, 2020
SUTRO BIOPHARMA, INC.5 tx · Oct 2, 2018
AGIOS PHARMACEUTICALS, INC.7 tx · $100.7M · Jan 23, 2018
26 tx · $42M · Dec 7, 2017
5 tx · $10M · Apr 13, 2017
3 tx · $10M · Feb 1, 2017
2 tx · $10.5M · Apr 1, 2005

Track record of CELGENE CORP /DE/

Statistical track record

Free account

Open-market buys: 16

Last buy: Jul 1, 2020

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of CELGENE CORP /DE/

Co-insiders of CELGENE CORP /DE/

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACCELERON PHARMA INCListing unverified	Jul 13, 2020	Sell	-2,241	102.28 USD	$229.2K		SEC
ACCELERON PHARMA INCListing unverified	Jul 13, 2020	Other	38,979	5.88 USD	$229.2K		SEC
ACCELERON PHARMA INCListing unverified	Jul 13, 2020	OtherD (derivative)	-38,979	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Jul 6, 2020	Buy	108,108	92.50 USD	$10M	conv 23First in 12mo	SEC
ACCELERON PHARMA INCListing unverified	Jan 22, 2019	Buy	706,206	43.00 USD	$30.4M	conv 23	SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	Other	1,726,197	—	n/a (No price was disclosed in the filing)		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-18,726,075	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-8,338,892	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-18,097,331	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-2,845,114	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AGIOS PHARMACEUTICALS, INC.Listing on record	Jan 23, 2018	Buy	851,154	67.00 USD	$57M	conv 61Unusual size	SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-12,666	19.04 USD	$241.2K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-23,000	18.54 USD	$426.4K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-4,263	19.25 USD	$82.1K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-16,875	18.06 USD	$304.8K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-14,907	17.19 USD	$256.3K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-51,282	18.44 USD	$945.6K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-5,080	19.22 USD	$97.6K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-30,485	19.47 USD	$593.5K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-158,718	19.02 USD	$3M	Unusual size	SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-105,000	18.39 USD	$1.9M	Unusual size	SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-87,991	19.10 USD	$1.7M		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-22,759	19.10 USD	$434.7K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-20,000	17.08 USD	$341.6K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-10,000	17.28 USD	$172.8K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACCELERON PHARMA INCListing unverified	Jul 13, 2020	Sell	-2,241	102.28 USD	$229.2K		SEC
ACCELERON PHARMA INCListing unverified	Jul 13, 2020	Other	38,979	5.88 USD	$229.2K		SEC
ACCELERON PHARMA INCListing unverified	Jul 13, 2020	OtherD (derivative)	-38,979	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Jul 6, 2020	Buy	108,108	92.50 USD	$10M	conv 23First in 12mo	SEC
ACCELERON PHARMA INCListing unverified	Jan 22, 2019	Buy	706,206	43.00 USD	$30.4M	conv 23	SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	Other	1,726,197	—	n/a (No price was disclosed in the filing)		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-18,726,075	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-8,338,892	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-18,097,331	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SUTRO BIOPHARMA, INC.Listing on record	Oct 2, 2018	OtherD (derivative)	-2,845,114	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
AGIOS PHARMACEUTICALS, INC.Listing on record	Jan 23, 2018	Buy	851,154	67.00 USD	$57M	conv 61Unusual size	SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-12,666	19.04 USD	$241.2K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-23,000	18.54 USD	$426.4K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-4,263	19.25 USD	$82.1K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-16,875	18.06 USD	$304.8K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-14,907	17.19 USD	$256.3K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-51,282	18.44 USD	$945.6K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-5,080	19.22 USD	$97.6K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-30,485	19.47 USD	$593.5K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-158,718	19.02 USD	$3M	Unusual size	SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-105,000	18.39 USD	$1.9M	Unusual size	SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-87,991	19.10 USD	$1.7M		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-22,759	19.10 USD	$434.7K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-20,000	17.08 USD	$341.6K		SEC
CRISPR Therapeutics AGListing on record	Dec 7, 2017	Sell	-10,000	17.28 USD	$172.8K		SEC